Literature DB >> 10532395

The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations.

K Hirayama1, J Rafter.   

Abstract

Colorectal cancer is one of the most important causes of cancer morbidity and mortality in Western countries. While a myriad of healthful effects have been attributed to the probiotic lactic acid bacteria, perhaps the most controversial remains that of anticancer activity. It should be pointed out already at this point that there is no direct experimental evidence for cancer suppression in humans as a result of consumption of lactic cultures in fermented or unfermented dairy products. However, there is a wealth of indirect evidence, based largely on laboratory studies, in the literature. The precise mechanisms by which lactic acid bacteria may inhibit colon cancer are presently unknown. However, such mechanisms might include: enhancing the host's immune response; binding and degrading potential carcinogens; quantitative and/or qualitative alterations in the intestinal microflora incriminated in producing putative carcinogen(s) and promoters (e.g. bile acid-degrading bacteria); producing antitumorigenic or antimutagenic compounds in the colon; alteration of the metabolic activities of intestinal microflora; alteration of physicochemical conditions in the colon; effects on physiology of the host. These potential mechanisms are discussed in the present paper.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532395     DOI: 10.1007/978-94-017-2027-4_25

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  12 in total

Review 1.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

2.  Caregivers' knowledge and use of fermented foods for infant and young children feeding in a rural community of odi, gauteng province, South Africa.

Authors:  Paul K Chelule; Mathildah M Mokgatle; Lindiwe I Zungu; Armelia Chaponda
Journal:  Health Promot Perspect       Date:  2014-07-12

3.  Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.

Authors:  Razek Coussa; Christopher Martoni; Jasmine Bhathena; Aleksandra Malgorzata Urbanska; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2010-07-27

4.  Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.

Authors:  Bong Seon Kang; Jae-Gu Seo; Gwa-Su Lee; Jung-Hwa Kim; Sei Yeon Kim; Ye Won Han; Hoon Kang; Hyung Ok Kim; Ji Hwan Rhee; Myung-Jun Chung; Young Min Park
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

Review 5.  Emerging roles of lactic acid bacteria in protection against colorectal cancer.

Authors:  Li Zhong; Xufei Zhang; Mihai Covasa
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.

Authors:  Satya Prakash; Mitchell Lawrence Jones
Journal:  J Biomed Biotechnol       Date:  2005

Review 7.  Health benefits of probiotics: a review.

Authors:  Maria Kechagia; Dimitrios Basoulis; Stavroula Konstantopoulou; Dimitra Dimitriadi; Konstantina Gyftopoulou; Nikoletta Skarmoutsou; Eleni Maria Fakiri
Journal:  ISRN Nutr       Date:  2013-01-02

8.  Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy.

Authors:  Maha A Khalil; Mostafa M El-Sheekh; Hala I El-Adawi; Nehal M El-Deeb; Mohamed Z Hussein
Journal:  J Res Med Sci       Date:  2015-10       Impact factor: 1.852

9.  Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14.

Authors:  Zhu Zeng; Rui Yu; Fanglei Zuo; Bo Zhang; Deju Peng; Huiqin Ma; Shangwu Chen
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

10.  Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells.

Authors:  Bo Zhang; Angdi Li; Fanglei Zuo; Rui Yu; Zhu Zeng; Huiqin Ma; Shangwu Chen
Journal:  Microb Cell Fact       Date:  2016-06-10       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.